Your browser doesn't support javascript.
loading
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.
Yao, James C; Fazio, Nicola; Singh, Simron; Buzzoni, Roberto; Carnaghi, Carlo; Wolin, Edward; Tomasek, Jiri; Raderer, Markus; Lahner, Harald; Voi, Maurizio; Pacaud, Lida Bubuteishvili; Rouyrre, Nicolas; Sachs, Carolin; Valle, Juan W; Fave, Gianfranco Delle; Van Cutsem, Eric; Tesselaar, Margot; Shimada, Yasuhiro; Oh, Do-Youn; Strosberg, Jonathan; Kulke, Matthew H; Pavel, Marianne E.
Afiliação
  • Yao JC; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jyao@mdanderson.org.
  • Fazio N; Istituto Europeo di Oncologia, IRCCS, Milan, Italy.
  • Singh S; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Buzzoni R; Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
  • Carnaghi C; IRCCS Istituto Clinico Humanitas, Rozzano, Italy.
  • Wolin E; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Tomasek J; Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Raderer M; Univ. Klinik f. Innere Medizin I, AKH, Vienna, Austria.
  • Lahner H; Universitaetsklinikum Essen, Zentrum f. Innere Medizin, Essen, Germany.
  • Voi M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Pacaud LB; Novartis Pharma AG, Basel, Switzerland.
  • Rouyrre N; Novartis Pharma AG, Basel, Switzerland.
  • Sachs C; Novartis Pharma AG, Basel, Switzerland.
  • Valle JW; Institute of Cancer Studies, University of Manchester, The Christie Hospital, Manchester, UK.
  • Fave GD; Azienda Ospedaliera Sant'Andrea, Università La Sapienza, Rome, Italy.
  • Van Cutsem E; University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium.
  • Tesselaar M; Nederlands Kanker Instituut, Antoni van Leeuwenhoek, Amsterdam, Netherlands.
  • Shimada Y; National Cancer Center Hospital, Tokyo, Japan.
  • Oh DY; Seoul National University Hospital, Seoul, South Korea.
  • Strosberg J; Moffitt Cancer Center, Tampa, FL, USA.
  • Kulke MH; Dana Farber Cancer Institute, Boston, MA, USA.
  • Pavel ME; Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
Lancet ; 387(10022): 968-977, 2016 Mar 05.
Article em En | MEDLINE | ID: mdl-26703889
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Everolimo / Neoplasias Gastrointestinais / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Everolimo / Neoplasias Gastrointestinais / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2016 Tipo de documento: Article